Sequence-diversity-guided discovery, model-guided mutagenesis, and secretory production of GH5 endoglucanases in Bacillus subtilis
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Sequence-model-guided selection plus direct biochemical assays establishes previously uncharacterized active GH5 enzymes and production result. Explicitly preserve imperfect predictions, purified/flask scale and no industrial deployment claim.
Technology: CatPred sequence model for screening GH5 endoglucanases and guiding mutagenesis
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- CatPred sequence-model screening prioritizes GH5 enzymes; selected candidates undergo mutagenesis, secretion and biochemical activity testing.
- Limitation / still unknown
- Results are limited to the reported models, cohorts, datasets or experiments; broader generalization and clinical or operational benefit were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1186/s13068-026-02838-3
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.